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Modulation of hypoxia.induced calpain activity in rat renal proximal
tubules. The effect of the newly developed, nonpeptide, calpain inhibitor,
PD 150606, on hypoxia and ionomycin-induced increases in calpain
activity in rat proximal tubules (PT) was determined. PD150606 inhibited
both hypoxia and ionomycin-induced calpain activity as determined by the
fluorescent substrate N-succinyl-Leu-Leu-Val-Tyr-7-amido-4-methyl cou-
mann (N-succinyl-Leu-Lcu-Val-Tyr-AMC). This decrease in calpain ac-
tivity was accompanied by dose-dependent cytoprotection against hypoxia
and ionomycin-induced cell membrane damage. PD150606 had no effect
on cathepsin B and L activity in PT as measured by the fluorescent
substrate, henzyloxycarbonyl-L-phcnylalanyl-L-arginine-7-amido-4-methyl
coumarin (Z-Phe-Arg-AMC). The effects of low intracellular pH (pHi) or
low free cytosolic calcium [Ca2*lj on this hypoxia-induced calpain activity
were also determined. Both low pH and low [Ca2'] attenuated the
hypoxia-induced increase in calpain activity. This attenuation of calpain
activity was observed early before hypoxia-induced membrane damage
and was associated with marked reduction in the typical pattern of
hypoxia-induced cell membrane damage observed in this model. To
identify the isoform of calpain activated in rat proximal tubules, normoxic,
hypoxic and ionomycin treated tubules were fractionated by MONO-Q
anion exchange chromatography and the fractions were assayed for
calpain activity. A single peak of calpain activity characteristic of j.t-calpain
was found. The calcium dependency of the calpain activity was in the
nanomolar range, further confirming that the activity was the low Ca2-
sensitive /L-calpain. The present study suggests that in rat proximal
tubules: (1) PD 150606 is a specific inhibitor of calpain and not cathepsins
B and L; (2) the cytoprotective effects of low pH and low [Ca2J are
mediated, at least in part, by inhibition of calpain activity; and (3) the
predominant active form of calpain is the isoenzyme r-calpain.
Calpain is a calcium-dependent neutral cysteine protease that
has been implicated in ischemic damage to brain, liver and
myocardium [1-41. However, there are few studies on the role of
calpain in renal tubule pathophysiology. Calpain plays a role in
cyclosporine toxicity in primary cultures of renal proximal tubules
[5] and in HgCI2 toxicity in cultured proximal tubules [61. We have
recently demonstrated that calpain is a mediator of hypoxic injury
in renal proximal tubules [7]. In this previous study, inhibition of
hypoxic and ionomycin-induced increases in calpain activity with
chemically dissimilar cysteinc protcase inhibitors elicited cytopro-
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tection against accompanying proximal tubular cell membrane
damage [7]. The effects of specific calpain inhibition, low intra-
cellular pH (pH1) and low free cytosolic calcium [Ca2]1 on
hypoxia-induced calpain activation have however not been exam-
ined. The specific calpain isoform involved in hypoxic proximal
tubule damage has also not been identified. The development of
cell permeable cysteine protease inhibitors has facilitated the
study of the role of calpain in cell injury [8]. However, commonly
used calpain inhibitors bind to the active cysteine site on cysteine
proteases and therefore inhibit other cysteine proteases such as
the cathepsins B, H, L and S in addition to calpain. However, a
newly developed inhibitor, PD150606, binds to the calcium bind-
ing site of calpain and is recently proposed to be a specific
inhibitor of calpain and not cathepsins [9]. Thus, studies to
determine the effect of selective calpain inhibition on cysteine
protease activity and cell membrane injury in the proximal tubule
need to be conducted.
Secondly, it is known that both low pH and low Ca2 buffers are
cytoprotective against hypoxic/ischemic injury [10, 11]. Since
calpain activity, which has a neutral pH optimum, would be
expected to be inhibited by low pH, it is possible that part of the
protective effect of low pH may be through calpain inhibition.
Similarly, since calpain is Ca2-activated, the protection of low
[Ca2I1 may also be related to inhibition of calpain activity. The
effect of low pH1 and low [Ca2]1 on this hypoxia-induced calpain
activation and associated cell membrane damage has not hereto-
fore been studied.
Lastly, there are two major isoforms of calpain, the low calcium
sensitive j.r-calpain (formerly called calpain I) and the high
calcium sensitive m-calpain (formerly called calpain II) [12]. As
[Ca2] rises to 390 flM before hypoxic injury in our proximal
tubule preparation [13], it could be postulated that the low
calcium sensitive j.r-calpain is the isoform involved in hypoxic
injury. However, the active isoform of calpain present in the
kidney is controversial and the active isoform of calpain in
proximal tubules is unknown.
With this background, the aims of the present study were to
determine in proximal tubules: (1) the effect of selective calpain
inhibition on hypoxia-induced calpain activation; (2) the effect of
low pH1 and low [Ca2]1 on this calpain activation and subsequent
cell membrane damage; and (3) the isoform of calpain involved in
hypoxic tubular cell membrane damage.
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Methods
Reagents
Glycine, digitonin, N-succinyl-Leu-Tyr-AMC, hyaluronidase
type III from sheep testes, polyoxyethylene 23 lauryl ether (Brij 35
solution), dimethyl sulfoxide (DMSO) and N,N-dimethylform-
amide (DMF) were purchased from Sigma Chemical Co. (St.
Louis, MO, USA). PD150606 [2]-3-(4-iodophenyl)-2-mercapto-
2-propenoic acidi was provided by Warner Lambert Pharmaceu-
tical Company (Ann Arbor, MI, USA). N-succinyl-Leu-Leu-Val-
Tyr-AMC, Z-Phe-Arg-AMC and AMC were made by Peptide
Institute (Osaka, Japan), and obtained from Peptides Interna-
tional (Louisville, KY, USA). lonomycin, purified jr-calpain (from
porcine erythrocytes) and purified m-calpain (from porcine kid-
ney) were purchased from Calbiochem (San Diego, CA, USA);
Collagenase type B (lot number 0FAA133) from Boehringer
Mannheim (Indianapolis, IN, USA); i,22-Bis(2-aminophenoxy)
ethane-N,N,N',N'-tetraacetic acid (BAPTA) and fura 2 pentapotas-
sium from Molecular Probes (Eugene, OR, USA) and fatty acid-free
bovine albumin from ICN (Cleveland, OH, USA).
Preparation of tubules
Proximal tubules were isolated from kidney cortex of male
Sprague-Dawley rats (200 to 300 g body wt) using collagenase
digestion and Percoll centrifugation [14, 15J. Tubules were sus-
pended in a medium containing in (mM): 106 NaC1, 18 NaHCO3,
5 KCI, 1 CaC1, 2 Na2HPO4, 1 MgSO4, 5 glucose, 2,5 HEPES, 2
glutamine, 10 sodium butyrate and 4 sodium lactate. 6 ml aliquots
of tubule suspension (— ito 2 mglml) were placed in siliconized 25
ml Erlenmeyer flasks for a "recovery" period consisting of the
following: (1) gassing with 95% 02—5% CO2 for five minutes on
ice; (2) flasks were then capped with rubber stoppers and kept at
room temperature for five minutes; and (3) flasks were then
placed in a shaking water bath at 37°C for 10 minutes. To create
hypoxia, the tubule suspension was regassed for five minutes with
95% N—5% CO2 at a rate of 3 liter/mm [16]. After regassing, the
flasks were closed and kept in the shaking water bath for the
period of hypoxia studied. At the end of the hypoxic period, 1 ml
of tubule suspension was sampled for measurement of LDH and
cathepsin activity, and 2 ml for calpain activity.
The calcium ionophore, ionomycin, was used to induce a
dose-dependent increase in [Ca2]1 [17]. Normoxic tubules were
exposed to ionomycin (5 /LM or 10 ILM) for five minutes.
Measurement of LDH release and protein
LDH release was measured to evaluate cell damage, as previ-
ously described [14, 18]. The percentage of LDH released from
tubules was calculated by determining the ratio of LDH in the
supernatant compared to that in the lysed tubule pellet plus the
supernate. Protein was measured by the Lowry method using
bovine serum albumin as standard [19].
Calpain assay
The calpain assay used in this study is based on that described
by Sasaki et al for purified porcine kidney calpain [20]. The
preparation of cytosolic extracts from proximal tubules and the
calpain assay in freshly isolated proximal tubules has recently
been described in detail by us [7]. N-succinyl-Leu-Leu-Val-Tyr-
AMC was used as a susceptible substrate for calpain [20]. A stock
solution of 10 m was prepared in DMSO and stored at —20°C
between use.
Briefly, the calpain assay was performed as follows. After
exposure to normoxia, to ionomycin or to hypoxia, the tubule
pellet was separated from 2 ml tubule suspension by centrifuga-
tion. The Tmidazole-HC1 buffer used contained (in mM) Imidazole
63.2 and mercaptoethanol 10, pH 7.3. The tubule pellet was
immediately resuspended in a calcium-free Imidazole-HC1 buffer
containing in addition 1 mvt EDTA and 10 mtvi EGTA, pH 7.3.
The suspension was then incubated with digitonin (10 jxM) at 37°C
in a shaking water bath for five minutes. Ten micromolars of
digitonin selectively permeabilized the plasma membrane but did
not destroy lysosomal or mitochondrial membranes of hepato-
cytes [21] or mitochondrial membranes of rat proximal tubules
[11]. In separate experiments, using the lysosomal dye Lucifer
Yellow and a video imaging microscope previously described [13].
our laboratory confirmed that 10 jxM digitonin selectively perme-
abilized the plasma membrane of isolated rat proximal tubules
without affecting the lysosomal membrane. Thus 10 jIM digitonin
released cytosolic enzymes including calpain, while keeping the
lysosomal membrane intact.
After incubation with digitonin, the tubule pellet and superna-
tant containing released cytosolic calpain were again separated by
centrifugation. Calpain activity in the tubule pellet after digitonin
incubation was zero, confirming that all the calpain had been
released into the supernatant (cytosolic extract). The calpain
assay was then performed on this supernatant as follows: 0.5 ml
supernatant (0.5 to 1 mg tubule protein) was preincubated with
imidazole buffer with or without 5 mi CaCI2 for 10 minutes at
37°C in a shaking water bath. After 10 minutes of preincubation,
10 jIl of the substrate N-succinyl-Leu-Leu-Val-Tyr-AMC was
added. The total volume of the assay solution was made up to 2 ml
with the imidazole buffer. Incubation was continued for a further
30 minutes at 37°C in the shaking water bath. In the assay
performed without CaC12, the Imidazole-HCI buffer containing I
mM EDTA and 10 mrvi EGTA was used. After the 30 minute
incubation, fluorescence at 380 nm excitation and 460 nm emis-
sion was determined. Calpain activity was determined as the
difference between the calcium dependent fluorescence and the
non-calcium dependent fluorescence. An AMC standard curve
was determined for each experiment. Calpain activity was ex-
pressed in pmol AMC released per minute of incubation time per
mg of tubule protein.
Calpain activity measured in the media used for incubation of
the tubules was negligible in normoxia, hypoxia and ionomycin
treatment, confirming that calpain does not leak out of the tubulcs
into the media [7].
The calpain substrate used in our assay, N-succinyl-Leu-Leu-
Val-Tyr-AMC, can be proteolyzed in vitro by the cathepsin,
papain [20]. Therefore, to ensure the calpain selectivity of our
assay and exclude any possible effect of lysosomal leakage of
cathepsins in our calpain assay, the following measures were
taken: (1) digitonin, which releases cytoplasmic contents while
keeping lysosomes intact, thus limiting release of lysosomal
cathepsins, was used to lyse the cells 113]; (2) the assay was
performed at a pH of 7.3 at which cathepsins are known to be
inactivated [22]; and (3) calpain activity was defined and calcu-
lated as calcium-dependent activity, thus excluding cathepsin
activity that is strictly calcium-independent [22].
Where indicated, calpain extracts were further fractionated by
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MONO-Q anion exchange chromatography. Samples were loaded
on a Pharmacia HR 5/5 MONO-Q column that had been equili-
brated with 4 mivi Tris/HC1 (pH 7.4), 1 ms'i EGTA, 1 mrvi EDTA
and 3 mi 2-mercaptoethanol [23]. The column was eluted with a
20 ml gradient from 0 to 700 mivi NaCI in the same buffer.
Fractions (1 ml) were collected and assayed for calpain activity
using the substrate N-succinyl-Leu-Tyr-AMC.
Cathepsin assay
The cathepsin assay used in this study is based on the assay for
cathepsin B developed by Barret and Kirschke [22] and has
recently been described in detail by us in proximal tubules [7].
Z-Phe-Arg-AMC was used as a specific substrate for cathepsins B
and L [22]. Cathepsins B and L cleave the substrate and release
AMC, which is highly fluorescent at 380 nm excitation and 460 nm
emission.
Solutions used for cathepsin assay. The tubules were homoge-
nized in a 10 m sodium phosphate buffer, pH 7.4. The incubation
solution contained in (mM) 11.5 Na2HPO4, 55.2 KI-12P04, 4
EDTA; it also contained 0.2% Triton X100 and 0.05% bovine
serum albumin. The pH of the incubation solution was 6.0.
Cathepsins B and L have an optimum pH for proteolytic activity
of 5.5 to 6.0, and they are irreversibly inactivated above a pH of 7
[22]. The stop solution contained 100 mrvi iodoacetate in a buffer
containing 30 mM sodium acetate and 70 m acetic acid. (pH
4.75). A 10 m stock solution of the substrate Z-Phe-Arg-AMC
was prepared in DMSO. The stock solution was freshly diluted
daily to a 1 m solution with 0.1% Brij solution. A total of 8 mM
cysteine was added to the 1 mM stock solution just before use.
After the period of normoxia and hypoxia studied, 1 ml of
tubule suspension was separated into a pellet and supernatant by
centrifugation. The tubule pellet was sonicated for 30 seconds in
4 ml of the phosphate buffer to release lysosomal enzymes and
then centrifuged at 10,000 g for 10 minutes. The cathepsin assay
was then performed on the tubule homogenate. Cathepsin activity
in the media of the tubule suspensions was previously determined
to be negligible [7].
The assay itself was performed as follows: 8 d of tubule
homogenate (0.005 to 0.01 mg tubule protein) was added to 100 ,td
of the incubation solution. After 10 minutes of preincubation in a
shaking water bath at 37°C, 50 xl of the substrate were added. The
incubation was continued for a further 30 minutes at 37°C in a
shaking water bath. At the end of the incubation period, 2 ml of
the stop solution was added to stop the enzyme reaction. Fluo-
rescence at 380 nm excitation and 460 nm emission was deter-
mined using a Hitachi F2000 spectrophotometer. An AMC stan-
dard curve was determined for each experiment. Activity of
cathepsins B and L in the tubules was expressed in nmol AMC
released per minute of incubation time per mg of tubule protein.
C'alpain inhibition studies
A stock solution of 10 m of the inhibitor PD150606 in DMF
was stored at —20°C. After the recovery period, the tubules were
preincubated with the inhibitor for 10 minutes at 37°C in the
shaking water bath. They were regassed with 95% 02—5% CO2 at
1 liter/mm for the first five minutes of the preincubation.
Video imaging fluorescence microscopy (VIFM)
Quantitative fluorescence video microscopy was performed on
a customized VIFM system that has been described in detail
elsewhere [24]. Briefly, a Nikon epifluorescence microscope is
interfaced to a PC computer with Universal Imaging Image/FL
software, which allows for multiple excitation ratio imaging. A
microperfusion chamber was mounted onto the stage of the
microscope. The design and configuration of the perfusion cham-
ber has been described previously [24]. It allows for continuous
perfusion of gassed buffer and meticulous control of the environ-
ment in which the tubules are visualized during microscopy. The
perfusion buffer contained (in mM): NaC1 113, NaHCO3 18, KC1
5, CaCI2 1, Na2HPO4 2, MgSO4 1, glucose 5, glutamine 1, sodium
butyrate 1, sodium lactate 1.
Intracellular pH measurements
Intracellular pH (pH) measurements were made using the
dual-excitation pH-sensitive fluorophore SNAFL-2 and VIFM.
SNAFL-2 fluoresces at 620 nm and the ratio of fluorescence
intensities when excited at 500 nm and 550 nm is proportional to
pHi. pH, calibration curves were performed by adding 5 xg/ml
nigericin to proximal tubules in a high K buffer (in mM): 120
KCI, 30 NaCl, 0.5 MgSO4, 1 CaCl2, I NaHPO4, 5 glucose, 10
HEPES, 10 PIPES [25]. The high K buffer was adjusted with 1 or
10 N NaOH to vaiying pH's to generate a calibration curve for
each experiment. Proximal tubules incubated in a buffer contain-
ing the 18 mivi NaHCO3 normally used (pH 7.35) had a baseline
pH of 7.35 0.07 (N = 6) that did not change during hypoxic
perfusion. When the tubules were incubated in a low pH buffer
containing 7.5 m NaHCO3 (pH 6.95), the baseline pH dropped
to 7.03 0.09 (N = 6). During hypoxic perfusion with the pH 6.95
buffer, the pH1 remained at 7.03 0.04 (N = 6).
Low pH and low Ca2 + studies
For low pH studies, after isolation, the tubules were recovered
in the low pH buffer. As described above, this buffer maintained
an intracellular pH of 7.03 during hypoxia, compared to 7.35 in
normoxic and hypoxic controls.
To evaluate the effect of low extracellular Ca2 on calpain
activity, two independent methods were used: a low Ca2 buffer
and the intracellular Ca2 chelator, BAPTA. Tubules were al-
lowed to "recover" in a medium containing 0.7 m'vi CaC12 and 1
mM EGTA. The use of 0.7 mi CaC12 and 1 mM EGTA lowered
extracellular calcium to a concentration of 100 n and prevented
the hypoxia induced rise in [Ca2]1 in rat proximal tubules [111.
Tubules were also incubated with BAPTA (100 xM) for 45
minutes at room temperature and then for 10 minutes at 37°
before the induction of hypoxia. This dose of BAPTA reduced the
[Ca2]1 in freshly isolated rat proximal tubules to approximately
80 n and prevented the hypoxia-induced rise in [Ca2I1 [13].
Rat lung extract
Partially purified m-calpain controls were obtained from nor-
mal nonperfused rat lung tissue by a technique modified from
Waxman and Krebs [26].
Determination of calcium dependency
Cytosolic extracts were diluted in Ca2/EGTA buffers contain-
ing various concentrations of free Ca2. Actual free Ca2 con-
centrations in the buffers was determined using fura-2 pentapo-
tassium and VIFM [131. Calpain activity was assayed using
N-succinyl-Leu-Leu-Val-Tyr-AMC as a substrate, as described
above.
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Fig. 1. Effect of the specific calpain inhibitor, PD150606, on tubular calpain
activity (A) and LDH release (B) after 15 minutes of hypoxia (H) and in
normoxic (N) controls (N = 5). Normoxic tubules were preincubated with
the calpain inhibitor PD150606 (10 /LM, 100 /LM) for 10 minutes before the
induction of hypoxia.
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Fig. 2. Effect of the specific calpain inhibitor, PD150606, on the ionomycin-
induced increase in calpain activity (A) and LDH release (B) in normoxic
(N) controls and no,moxic tubules incubated with i000mycin (I) (N = 5).
Normoxic tubules were preincubated with PD150606 (100 ISM) for 10
minutes. The same tubules were then incubated with lonomycin (5 xM) for
a further five minutes.
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Statistical analysis hypoxic injury (Fig. 1), does not inhibit cathepsin B and L activity
Multiple group comparisons were done using the analysis of
variance (ANOVA) with post-test according to Newman-Keuls. A
P value of less than 0.05 was considered statistically significant.
Values are expressed as means standard error (sEM).
in proximal tubules (Fig. 3).
In addition, PD 150606 (100 !LM) did not have a deleterious
effect on normoxic tubules. LDH release was 10 1% in controls
and 11 1% in controls treated with PD150606 (NS, N = 4).
Results Low fCa2J1 and low pH, inhibit hypoxia-induced (7.5 and 15
miii) calpain activity
PD150606 is an inhibitor of calpain activity and not cathepsin B
and L activity in proximal tubules
Tubule calpain activity was 7 7 pmol/min/mg protein in
normoxic controls and increased after 15 minutes hypoxia to
PD150606 induced a dose-dependent decrease in hypoxic cell 308 42 pmol!min/mg protein (P < 0.001, N = 5). Low [Ca2J,
membrane injury as assessed by LDI-l release (Fig. 1). This induced by a low Ca2 buffer, reduced calpain activity to 191 53
dose-dependent cytoprotection was accompanied by a dose-dc- pmol/min/mg protein (P < 0.05 vs. hypoxia, N = 5) and low pH
pendent decrease in calpain activity (Fig. 1). PD150606 also reduced calpain activity to 162 34 (P < 0.01 vs. hypoxia, N =5)
protected against ionomycin-induced increases in calpain activity at 15 minutes hypoxia (Fig. 4). The decrease in calpain activity
and LDH release (Fig. 2). induced by low pH and low [Ca211 was accompanied by marked
The effect of PD 150606 (100 ELM) on cathepsin B and L activity cytoprotection against hypoxic injury. LDH release was 10 2%
in normoxic tubules is shown in Figure 3. PD 150606 had no effect in normoxic controls, 42 3% after 15 minutes hypoxia (P <
on cathepsin B and L activity in normoxic and hypoxic tubules as 0.001, N = 5), 23 5% with low [Ca21 (P < 0.001 vs. hypoxia,
compared to previously tested inhibitors [7, 271. We have previ- N = 5) and 12 2% with low pH (P < 0.001 vs. hypoxia, N 5;
ously shown that cathepsin B and L activity is the same in Fig. 4).
normoxic versus hypoxic tubules [71. Thus PD150606, at a dose Calpain activity was also measured at 7.5 minutes hypoxia, a
that inhibits calpain activity and elicits cytoprotcction against time point before hypoxia-induced cell membrane damage as
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assessed by LDH release (Fig. 4). Calpain activity was 14 6
pmol/min/mg protein in normoxic controls, and increased after 7.5
minutes hypoxia to 178 37. Low [Ca2]1, induced by a low Ca2
buffer, reduced calpain activity to 94 6 pmol/min/mg protein
(P < 0.01 vs. hypoxia, N = 5) and low pH reduced calpain activity
to 86 19 (P < 0.01 vs. hypoxia, N = 5). Therefore, there was a
dramatic increase in calpain activity which preceded hypoxic
membrane damage. Both low (Ca2)1 and low pH1 significantly
prevented the increase in calpain activity at 7.5 minutes hypoxia.
Low [Ca2]1 was also induced using the intracellular Ca2
chelator, BAPTA. Calpain activity was 6 pmol!min/mg protein in
normoxic controls, 182 32 after 15 minutes hypoxia (P < 0.001
vs. normoxia) and 96 34 in hypoxic tubules preincubated with
100 LM BAPTA (P < 0.01 vs. hypoxia; Fig. 5). This decrease in
calpain activity was associated with significant cytoprotection
against hypoxic injury. LDH release was 10 1 in normoxic
controls, 36 2 after 15 minutes of hypoxia (P < 0.001 vs.
hypoxia, N = 5) and 21 3 in hypoxic tubules preincubated with
100 /.M BAPTA (P < 0.01 vs. hypoxia, N = 5; Fig. 5). BAPTA was
used in separate set of experiments as it requires 45 minutes
preincubation to enter the cell and chelate intracellular Ca2 [131
compared to the 20 minutes "recovery" for the low Ca2 and low
pH buffer. Despite the longer preincubation and different calpain
values, the percentage inhibition of calpain activity and the degree
of cytoprotection induced by BAPTA were similar to the low
Ca2 buffer.
MONO-Q anion exchange chromatography
A single peak of calpain activity was observed at 150 to 160 mrvi
NaCI, which corresponds with published reports of x-calpain (Fig.
6 A, B) [28]. Purified x-calpain also revealed a peak of activity at
B
P<o.oo1 P<o.o1 P<o.o1
a similar [NaC1] on MONO-Q anion exchange chromatography.
No tubular calpain activity was seen in the region of m-calpain
(Fig. 6 A, B). Purified m-calpain and rat lung extract, which
contains predominantly m-calpain, were used as positive controls
for m-calpain. 0.3 mg purified m-calpain and 2.6 mg rat lung
extract revealed single peaks of calpain activity at 470 mr'i NaCI
which corresponds with published reports of m-calpain (Fig. 6C)
[291. Thus the calpain activity in normoxic and hypoxic tubules is
due to x-calpain.
Calcium dependency of calpain activity
To confirm that the tubular calpain activity is due to the low
Ca2 sensitive, jx-calpain, the Ca2 dependency of the cytosolic
activity was determined. Activity of calpain was measured at
various Ca2 concentrations. In three separate experiments,
maximum calpain activity was achieved by 500 ns Ca2t Half-
maximal activity was obtained at approximately 250 to 300 nM
Ca2. A calcium dependency curve from one of the experiments
is shown in Figure 7.
Discussion
Calpain is the major cytosolic protease and the only Ca2-
dependent cytosolic protease described so far [30]. Calpain is now
known to be a mediator of hypoxic/ischemic injury to brain, liver,
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Fig. 3. Nonnoxic tubules were preincubated with PD150606 (100 juu), a
specific ca/pain inhibitor. PD150606, at a dose that significantly inhibited
hypoxia-induced calpain activity and LDH release (Fig. 1), had no effect
on tubular cathepsin B and L activity (N = 5).
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Fig. 5. Effect of/ow free cytosolic calcium [Ca2 induced by the intracel-
lular Ca2* chelator, BAPTA (100 pM), on tubular calpain activity (A) and
LDH release (B) after 15 minutes hypoxia (H) and in normoxic (N) controls
(N = 5).
heart and kidneys [1—4, 7]. Other studies of cysteine proteases and
proximal renal tubular damage have been confined to cyclospo-
rine [5] and HgC12 toxicity [61. In cultured tubules exposed acutely
to cyclosporine, calpain activity increased, but cathepsin activity
was not increased and lysosomes were intact; these results sug-
gested that calpain but not cathepsins are involved in acute
cyclosporine-induced renal tubular injury [5]. In proximal tubule
epithelial cells, HgCI2 toxicity correlated with increased ionized
Ca2 and the toxicity was diminished by calpain inhibitors [6].
The use of cell permeable cysteine protease inhibitors has
facilitated the study of the role of calpain in tissue damage.
However, the well-known peptide cysteine protcase inhibitors that
have been used to study the physiological and pathological role of
calpain in tissues have a lack of selectivity. This is because the
large catalytic subunit of both JL-calpain and m-calpain contains
an active cysteine residue that is also a characteristic of all cysteine
proteases including cathepsins B, H L and S. The lack of
selectivity of the cell permeable inhibitors (1) (2S,3S)-trans-
epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester (E-64-d)
and (2) N-benzyloxycarbonyl-Val-Phe-Methyl ester (Cbz-Val-
PheH) is most likely due to binding of these inhibitors to the
active site cysteine leading to inhibition of cathepsins as well as
calpain [31]. Thus, the effect of inhibition of cathepsins needs to
be considered when using these cysteine protease inhibitors to
study the specific role of calpain in cell injury. PD150606 is a
newly developed non-peptide calpain inhibitor. PD150606 has an
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Fig. 6. Calpain extra cts from normoxic (A) and hypoxic (S, 15 mm) tubules
(A), tubules treated with ionomycin (10 j.LM) for five minutes (B) and positive
controls for ca/pain II (C) (• lung extract; 0 porcine kidney) were fraction-
ated by MONO-Q anion exchange chromatography. One milliliter fractions
were assayed for calpain activity.
alpha mercaptoacrylate ring structure and is a potent inhibitor of
both p.- and m-ealpain with an inhibition constant (ki) of 0.21 jIM
and 0.37 p.M against p.- and m calpain, respectively. PD 150606
inhibits calpain by binding to the helix-loop-helix calcium binding
sites on calpain and not the active cysteine site. PD 150606 is a
specific inhibitor of calpain when tested against other proteases
like eathepsin B, papain, trypsin, and thermolysin. It does not
inhibit basal calcineurin, which also has EF-hand calcium binding
protein and was found to be very cell permeable. PD 150606 is
neuroproteetant; it protects against hypoxic injury and calpain-
induced spectrin breakdown in cerebrocortical cultures [9]. In the
present study, the effect of this new inhibitor, PD150606, on
calpain and cathepsin activity and cell membrane damage was
studied for the first time in renal proximal tubules. The selective
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Fig. 7. Calcium dependency of ca/pain activity. Calpain activity was mea-
sured using EGTA/Ca2 buffers with the indicated free Ca2 concentra-
tion as determined by Fura-2 and video imaging fluorescence microscopy
(VTFM).
effect of PD 150606 was demonstrated on calpain but not cathep-
sins B and L in the proximal tubule. Moreover, PD150606 elicited
cytoprotection against both hypoxic and ionomycin-induced cell
membrane damage confirming the role of calpain as a mediator of
hypoxic injury in rat proximal tubules. PD150606 thus represents
a novel way to study the role of calpain in physiological and
pathological processes in the proximal tubule.
As well as being Ca2-dependent, the activity of calpain is
highly pH-dependent. Calpain is active at neutral pH and is
inactivated at an acidic pH. In contrast, the lysosomal cathepsins
B and L are not Ca2-dependent, are active at an acidic pH and
inactivated at a pH above 6.5 [22]. We and others have demon-
strated that low pH1 prevents hypoxia-induced cell membrane
damage in proximal tubules [17, 32]. Low [Ca2]1 is also known to
be cytoprotective against hypoxic PT injury [11, 13, 33j. With this
background on the strict Ca2 and pH requirements of calpain
and the known cytoprotective effects of low [Ca2] and low pH1,
further studies were undertaken to determine whether the cyto-
protective effects of low [Ca21 and low pH1 involve calpain
inhibition.
With PD150606, nearly complete suppression of calpain activity
was required to obtain significant protection, while with low pH
and low Ca2 significant cytoprotection was obtained with only
50% suppression of calpain activity. The possible explanation for
this apparent lack of correlation between the amount of inhibition
of calpain activity with different agents and the degree of cyto-
protection, is that the cytoprotcctivc effect of low Ca2' and low
pH is not solely due to inhibition of calpain activity. There may
well be other factors besides calpain that account for the cytopro-
tection at low pH and low Ca2 [3—371
The present in vitro results must be interpreted relative to the in
vivo pH response to ischcmia. In our in vitro low pH experiments,
the pH of the tubule suspension is preset at 7.0, a pH that
significantly inhibits calpain activity. The in vivo situation is
different in that ischemia may induce an early rise in cytosolic
calcium that, at physiological pH, stimulates calpain activity (as
well as other Ca2 -dependent enzymes). Based on the present
results, however, it could postulated that a subsequent decrease in
pH stimulated by in vivo ischemia may well serve as a compensa-
tory mechanism to attenuate the detrimental enzyme activation
induced by the early rise in cytosolic calcium.
The results of the anion exchange chromatography fraction-
ation and the Ca2' sensitivity of the cytosolic activity demonstrate
that the predominant activity in rat proximal tubules is x-calpain,
the low calcium-sensitive isoenzyme of calpain. p.- and m calpain
have a sequence homology close to 90%. The structural difference
lies in the calcium binding domain consisting of four helix-loop-
helix structures, which defines the Ca2 sensitivity of calpain. As
used in the present study, anion exchange chromatography has
been extensively and reliably used to differentiate the activity of
the p. and m calpain isoforms in different tissues [23, 28, 29, 38,
10—6 391.
In conclusion, the present results demonstrate that (1) specific
inhibition of calpain activity with PD150606, independent of any
effect on cathepsin activity, affords cytoprotection against hypoxia-
induced proximal tubule damage; (2) the protective effect against
hypoxia-induced proximal tubule damage of low pH1 and inhibi-
tion of the rise in [Ca2], involves, at least in part, a decreased
activation of calpain; and (3) j.t-calpain, the low Ca2tsensitive
isoenzyme of calpain, predominates in the proximal tubule during
both normoxia and hypoxia.
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